Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000519990 | SCV000619723 | uncertain significance | not provided | 2017-08-07 | criteria provided, single submitter | clinical testing | The D104V variant in the MMACHC gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The D104V variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The D104V variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret D104V as a variant of uncertain significance. |
Ambry Genetics | RCV004948378 | SCV005443577 | uncertain significance | Inborn genetic diseases | 2024-11-13 | criteria provided, single submitter | clinical testing | The c.311A>T (p.D104V) alteration is located in exon 3 (coding exon 3) of the MMACHC gene. This alteration results from a A to T substitution at nucleotide position 311, causing the aspartic acid (D) at amino acid position 104 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001829506 | SCV002089531 | uncertain significance | Cobalamin C disease | 2020-10-21 | no assertion criteria provided | clinical testing |